CoChat

Spotlight on VSL#3 Probiotic Mixture in Chronic Inflammatory Bowel Diseases1

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

VSL#3 (VSL#3) is a high-concentration probiotic preparation of eight live freeze-dried bacterial species that are normal components of the human gastrointestinal microflora, including four strains of lactobacilli (Lactobacillus casei, L. plantarum, L. acidophilus, and L. delbrueckii subsp. bulgaricus), three strains of bifidobacteria (Bifidobacterium longum, B. breve, and B. infantis), and Streptococcus salivarius subsp. thermophilus. Data from noncomparative trials suggest that VSL#3 has clinical potential in the treatment of active mild to moderate ulcerative colitis and as maintenance therapy for patients with ulcerative colitis in remission. In addition, a randomized, open-label, multicenter trial showed that VSL#3 in combination with low-dose balsalazide (a prodrug of mesalazine [mesalamine; 5-aminosalicylic acid]) was more effective than standard doses of basalazide or mesalazine monotherapy in the treatment of acute mild to moderate ulcerative colitis. Randomized, double-blind, placebo-controlled studies have shown VSL#3 is effective in preventing the onset of acute pouchitis in patients with newly formed surgical pouches, and in maintaining remission following antibacterial treatment of acute pouchitis in patients with a history of refractory or recurrent pouchitis. Treatment guidelines from the US and the UK include VSL#3 as a therapeutic option for the prevention of pouchitis relapse in patients with chronic pouchitis. In general, VSL#3 was well tolerated in clinical trials. Large, well designed, controlled confirmatory clinical trials will further determine the place of VSL#3 in the treatment of ulcerative colitis.

Overview

Integrity signals

Registry

Crossref · 10.2165/00063030-200721010-00007

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 15 references

Cited by

See all 48

Metadata

Authors
Chapman, T. M., Plosker, G. L., & Figgitt, D. P.
Affiliations
Wolters Kluwer Health (NZ)
Corresponding author
Plosker, Greg L
Venue
BioDrugs
Published
2007
Volume
21
Issue
1
Pages
61-63
ISSN
  • 1172-7039 (ISSN-L)
  • 1173-8804
OpenAlex
W2000806325
Cited by
48
References
15
Citations by year
2026: 3 · 2025: 2 · 2024: 1 · 2023: 6 · 2022: 3 · 2021: 1 · 2020: 1 · 2018: 1 · 2017: 4 · 2015: 5 · 2014: 2 · 2013: 3 · 2012: 4
FWCI
5.96
Type
journal article
Language
en
Open access
closed
Locations
  • BioDrugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
VSL#3, probiotics, ulcerative colitis, Crohn's disease, inflammatory bowel disease, balsalazide, 5-aminosalicylic acid, pouchitis, Lactobacillus, Bifidobacterium, Streptococcus salivarius subsp. thermophilus, maintenance therapy, remission
MeSH terms
Humans, Inflammatory Bowel Diseases, Randomized Controlled Trials as Topic, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spotlight on VSL#3 Probiotic Mixture in Chronic Inflammatory Bowel Diseases1. https://app.cochat.ai/papers/10.2165/00063030-200721010-00007
The paper
Chapman, T. M., Plosker, G. L., & Figgitt, D. P. (2007). Spotlight on VSL#3 Probiotic Mixture in Chronic Inflammatory Bowel Diseases1. BioDrugs. https://doi.org/10.2165/00063030-200721010-00007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.